"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Autoantibodies
- Immune Sera
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in this website by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 4 | 5 |
| 1996 | 1 | 5 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 3 | 4 | 7 |
| 1999 | 2 | 5 | 7 |
| 2000 | 1 | 6 | 7 |
| 2001 | 2 | 3 | 5 |
| 2002 | 2 | 5 | 7 |
| 2003 | 1 | 7 | 8 |
| 2004 | 3 | 8 | 11 |
| 2005 | 4 | 8 | 12 |
| 2006 | 2 | 8 | 10 |
| 2007 | 2 | 3 | 5 |
| 2008 | 3 | 3 | 6 |
| 2009 | 3 | 4 | 7 |
| 2010 | 4 | 6 | 10 |
| 2011 | 1 | 6 | 7 |
| 2012 | 3 | 8 | 11 |
| 2013 | 5 | 5 | 10 |
| 2014 | 6 | 11 | 17 |
| 2015 | 2 | 10 | 12 |
| 2016 | 1 | 7 | 8 |
| 2017 | 3 | 6 | 9 |
| 2018 | 1 | 4 | 5 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 5 | 7 |
| 2021 | 4 | 1 | 5 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 6 | 6 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies" by people in Profiles.
-
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
-
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nat Commun. 2024 Jan 19; 15(1):615.
-
Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry. STAR Protoc. 2024 Mar 15; 5(1):102803.
-
Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications. Front Immunol. 2023; 14:1288802.
-
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes. Am J Hematol. 2024 02; 99(2):E32-E36.
-
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma. Eur J Cancer. 2024 Jan; 196:113441.
-
Antibody-directed extracellular proximity biotinylation reveals that Contactin-1 regulates axo-axonic innervation of axon initial segments. Nat Commun. 2023 10 26; 14(1):6797.
-
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies. Environ Res. 2023 Dec 15; 239(Pt 1):117297.
-
Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio. 2023 Oct 31; 14(5):e0061823.
-
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor. Clin Cancer Res. 2023 09 15; 29(18):3659-3667.